Erlotinib Has Moderate Single-agent Acti
β
Chadi Nabhan; Timothy M. Lestingi; Angel Galvez; Kathy Tolzien; Susan K. Kelby;
π
Article
π
2009
π
Elsevier Science
π
English
β 328 KB